Skip to main content
. Author manuscript; available in PMC: 2014 Jul 15.
Published in final edited form as: Cancer Res. 2013 May 30;73(14):4190–4195. doi: 10.1158/0008-5472.CAN-13-0465

Figure 4.

Figure 4

Differences in Alanine-to-Pyruvate flux ratio (Ala/Pyr) between (a) DMSO and BPTES groups (n = 8 for each group, error bars = s.d. from the mean, p<0.001) and (b) DMSO and FX11 groups (n = 8 for each group, error bars = s.d. from the mean, p = 0.112). Table I summarizes the FX11 and DMSO treatment response in terms of Lactate-to-Pyruvate flux ratio ((Lac/Pyr) and conversion rate constant ratio (kp/kL).